Metrics as of 10/14/2026, 08:31 AM (Berlin time), refresh in progress.
Amgen Stock
Amgen Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Robert A. Bradway
- Employees
- 31,500
- Market cap
- $17 B
- IPO
- 23/12/2025
Amgen Inc. is a biotechnology company operating within the Healthcare sector as a Drug Manufacturer, General. Headquartered in Thousand Oaks, US, the company employs 31,500 employees. Amgen Inc. engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded on April 8,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Amgen stock: price history
1D
+3.2%
1W
+3.4%
1M
+11.1%
6M
+21.7%
YTD
+26.6%
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Amgen
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
4,282
Dividends
Comparable stocks
Frequently asked questions about Amgen stock
What does Amgen do?
Amgen Inc. is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Robert A. Bradway, the company employs around 31,500 people.
The IPO was on 23/12/2025; the stock trades on TSX under the ticker AMGN.TO.
Does Amgen pay a dividend?
Yes. The last dividend was CA$0.19 per share, ex-date 21/08/2026, paid on 18/09/2026.
Which stocks are comparable to Amgen?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get Amgen stock analyzed?
Clicking "Analyze stock" lets five strategies assess Amgen against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.